請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37264
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 張鑾英(Luan-Yin Chang) | |
dc.contributor.author | Chia-Chi Cheng | en |
dc.contributor.author | 鄭嘉琪 | zh_TW |
dc.date.accessioned | 2021-06-13T15:22:51Z | - |
dc.date.available | 2010-08-14 | |
dc.date.copyright | 2008-08-14 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-07-23 | |
dc.identifier.citation | 1.Megraud F. Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am 1993; 22:73-88.
2.Graham DY, Malaty HM, Evans DG, et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States: effect of age, race and socioeconomic status. Gastroenterology 1991;100:1495–1501. 3.Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991;302:1302–1305. 4.Lacy BE, Rosemore J. Helicobacter pylori: Ulcers and more: the beginning of an era. J Nutr 2001;131:2789S-2793S. 5.Bravo LE, Mera R, Reina JC, Pradilla A, Alzate A, Fontham E, Correa P. Impact of Helicobacter pylori infection on growth of children: a prospective cohort study. J Pediatr Nutr 2003;37:614-619. 6.Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Fetal intrauterine growth restrictions with Helicobacter pylori infection. Alim Pharmacol Ther 2002; 16:1677-1682. 7.Taiwan cancer registry annual report. http://crs.cph.ntu.edu.tw/crs_c/annual.html. 8.Webb PM, Knight T, Greaves S, Wilson A, Newell DG, Elder J, Forman D. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ 1994;19:750-753. 9.Wu TC, Chen LK, Hwang SJ. Seroprevalence of Helicobacter pylori in school-aged Chinese in Taipei City and relationship between ABO blood groups. World J Gastroenterol 2003;9:1752-1755. 10.Chen LK, Hwang SJ, Wu TC, Chu CH, Shaw CK. Helicobacter pylori and hepatitis A virus infection in school-aged children on two isolated neighborhood islands in Taiwan. Helicobacter 2003;8:168-172. 11.Lin JT, Wang LY, Wang JT, Wang TH, Chen CJ. Ecological study of association between Helicobacter pylori infection and gastric cancer in Taiwan. Digestive Disease and Sciences 1995;40:385-388. 12.Lin DB, Nieh WT, Wang HM, Hsiao MW, Ling UP, Changlai SP, Ho MS, You SL, Chen CJ. Seroepidemiology of Helicobacter pylori infection among preschool children in Taiwan. Am J Trop Med Hyg 1999;61:554-558. 13.Wang LY, Lin JT, Cheng YW, Chou SJ, Chen CJ. Seroepidemiology of Helicobacter pylori among adolescents in Taiwan. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 1996;29:10-17. 14.Lee IH, Ni YH, Chang MH. Stable seroprevalence of Helicobacter pylori infection in children during 1989-1999 in Taipei, Taiwan. Pediatr Int 2004;46:311-314. 15.Lin HY, Chuang CK, Lee HC, Chiu NC, Lin SP, Yeung CY. A seroepidemiologic study of Helicobacter pylori and hepatitis A virus infection in primary school students in Taipei. J Microbiol Immunol Infect 2005;38:176-182. 16.Tsai CJ, Chang MH. Seroepidemiologic study of Helicobacter pylori infection in children in Taipei city. Acta Paed Sin 1995;36:254-256. 17.Weill FX, Margeridon S, Broutet N, Le Hello S, Neyret C, Megraud F. Seroepidemiology of Helicobacter pylori infection in Guadeloupe. Trans R Soc Trop Med Hyg 2002;96:517-519. 18.Selimoglu MA, Ertekin V, Inandi T. Seroepidemiology of Helicobacter pylori infection in children living in eastern Turkey. Pediatr Int 2002;44:666-669. 19.Goh KL, Parasakthi N. The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country. Eur J Gastroenterol Hepatol 2001;13:177-183. 20.Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Hawkey C, Atherton JC. High prevalence of potentially virulent strains of Helicobacter pylori in the general male British population. Gut 2000;47:23-25. 21.Lindo JF, Lyn-Sue AE, Palmer CJ, Lee MG, Vogel P, Robinson RD. Seroepidemiology of Helicobacter pylori infection in a Jamaican community. Trop Med Int Health 1999;4:862-866. 22.Alaganantham TP, Pai M, Vaidehi T, Thomas J. Seroepidemiology of Helicobacter pylori infection in an urban, upper class population in Chennai. Indian J Gastroenterol 1999;18:66-68. 23.Youn HS, Baik SC, Cho YK, Woo HO, Ahn YO, Kim K, Cho MJ, Lee WK, Ko GH, Okada K, Ueda K, Rhee KH. Comparison of Helicobacter pylori infection between Fukuoka, Japan and Chinju, Korea. Helicobacter 1998;3:9-14. 24.Horiuchi T, Ohkusa T, Watanabe M, Kobayashi D, Miwa H, Eishi Y. Helicobacter pylori DNA in drinking water in Japan. Microbiol Immunol 2001;45:515-519. 25.McDaniels AE, Wymer L, Rankin C, Haugland R. Evaluation of quantitative real time PCR for the measurement of Helicobacter pylori at low concentrations in drinking water. Water Res 2005;39:4808-4816. 26.Queralt N, Bartolomé R, Araujo R. Detection of Helicobacter pylori DNA in human faeces and water with different levels of faecal pollution in the north-east of Spain. J Appl Microbiol 2005;98:889-895. 27.Moayyed P, Axon ATR, Feltbower R, Duffett S, Crocombe W, Braunholtz D, Richards ID, Dowell AC, Forman D, Leeds HELP Study Group. Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol 2002;31:624-631. 28.McQuillan GM, Kruszon-Moran D, Kottiri BJ, Curtin LR, Lucas JW, Kington RS. Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III, 1988–1994. Am J Public Health 2004;94:1952-1958. 29.Mégraud F, Brassens-Rabbé MP, Denis F, Belbouri A, Hoa DQ. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 1989;27:1870-1873. 30.Mitchell HM, Lee A, Berkowicz J, Borody T. The use of serology to diagnose active Campylobacter pylori infection. Med J Aust 1988;149:604-609. 31.Jones DM, Eldridge J, Fox AJ, Sethi P, Whorwell PJ. Antibody to the gastric campylobacter-like organism ('Campylobacter pyloridis')--clinical correlations and distribution in the normal population. J Med Microbiol 1986;22:57-62. 32.al Moagel MA, Evans DG, Abdulghani ME, et al. Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudia Arabia, and comparison of those with and without upper gastrointestinal symptoms. Am J Gastroenterol 1990; 85:944-948. 33.Graham DY, Adam E, Reddy GT, et al. Seroepidemiology of Helicobacter pylori infection in India: comparison of developing and developed countries. Dig Dis Sci 1991;36:1084-1088. 34.Perez-Perez GI, Taylor DN, Bodhidatta L, et al. Seroprevalence Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis 1990;161:1237-1241. 35.Malaty HM, Graham DY, Wittingty WA, et al. Helicobacter pylori acquisition in childhood: a 12-year follow-up cohort study in a bi-racial community. Clin Infect Dis 1999;28:279–282. 36.Malaty HM, Graham DY. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 1994;35:742–745. 37.Malaty HM, Graham DY, Logan ND. Helicobacter pylori infection in preschool and school age minority children attending day care centers: effect of socioeconomic indicators and breast feeding practice. Clin Infect Dis 2001;32:1387–1392. 38.Malaty HM, El Kasaban AB, Graham DY, et al. Age of acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 2002;359:931–935. 39.Teh BH, Lin JT, Pan WH, Lin SH, Wang LY, Lee TK, Chen CJ. Seroprevalence and associated risk factors of Helicobacter pylori infection in Taiwan. Anticancer Res 1994;14:1389-1392. 40.Fiedorek SC, Malaty HM, Evans DL, Pumphrey CL, Casteel HB, Evans DJ Jr, Granham DY. Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics 1991; 88: 578-582. 41.Stone MA, Taub N, Barnett DB, Mayberry JF. Increased risk of infection with Helicobacter pylori in spouses of infected subjects: observations in a general population sample from the UK. Hepato-Gastroenterology 2000;47:433-436. 42.Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiologic Reviews 2000;22:283-297. 43.Roosendaal R, Kuipers EJ, Buitenwerf J, van Uffelen C, Meuwissen SG, van Kamp GJ, Vandenbroucke-Grauls CM. Helicobacter pylori cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997;92:1480–1482. 44.Cullen DJ, Collins BJ, Christiansen KJ, Epis J, Warren JR, Surveyor I, Cullen KJ. When is Helicobacter pylori infection acquired? Gut 1993;34:1681-1682. 45.Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis. 1993;168:219-221. 46.Haruma K, Okamoto S, Kawaguchi H, Gotoh T, Kamada T, Yoshihara M, Sumii K, Kajiyama G. Reduced incidence of Helicobacter pylori infection in young Japanese persons between the 1970 and the 1990s. J Clin Gastroenterol 1997;25:583–586. 47.Redlinger T, O'Rourke K, Goodman KJ. Age distribution of Helicobacter pylori seroprevalence among young children in a United States/Mexico border community: evidence for transitory infection. Am J Epidemiol 1999;150:225-230. 48.Lindkvist P, Asrat D, Nilsson I, et al. Age at acquisition of Helicobacter pylori infection: comparison of a high and a low prevalence country. Scand J Infect Dis 1996;28:181-184. 49.Blecker U, Hauser B, Landers S, et al. The prevalence of Helicobacter pylori-positive serology in asymptomatic children. J Pediatr Gastroenterol Nutr 1993;16:252-256. 50.Mahalanabis D, Rahman MM, Sarker SA, et al. Helicobacter pylori infection in the young in Bangladesh: prevalence, socioeconomic and nutritional aspects. Int J Epidemiol 1996;25:894-898. 51.Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 2000;29:559-578. 52.Harford WV, Barnett C, Lee E, Perez-Perez G, Blaser MJ, Peterson WL. Acute gastritis with hypochlorhydria: report of 35 cases with long term follow up. Gut 2000;47:467-472. 53.Borody T, Andrews P, Mancuso N, Jankiewicz E, Brandl S. Helicobacter pylori re-infection 4 years post-eradication. Lancet 1992;339:1295. 54.Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, Marshall BJ, Collins BJ. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994;343:258-260. 55.Thomas JE, Dale A, Harding M, Coward WA, Cole TJ, Weaver LT. Helicobacter pylori colonization in early life. Pediatr Res 1999;45:218-223. 56.Leal-Herrera Y, Torres J, Monath TP, et al. High rates of recurrence and of transient re-infections of Helicobacter pylori in a population with high prevalence of infection. Am J Gastroenterol 2003;98:2395–2402. 57.Soto G, Bautista CT, Roth DE, et al. Helicobacter pylori infection is common in Peruvian adults after antibiotic eradication therapy. J Infect Dis 2003;188:1263–1275. 58.Mapstone NP, Lynch DA, Lewis FA, Axon AT, Tompkins DS, Dixon MF, Quirke P. PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet 1993;341:447. 59.Parsonnet J, Shmuely H, Haggerty T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 1999;282:2240-2245. 60.Dore MP, Osato MS, Malaty HM, Graham DY. Characterization of a culture method to recover Helicobacter pylori from the feces of infected patients. Helicobacter 2000;5:165-168. 61.Malaty HM, Tanaka E, Kumagai T, Otah H, Kiyosawa K, Graham DY, Katsuyama T. Seroepidemiology of Helicobacter pylori and hepatitis A virus and the model of transmission of infection: a 9-year cohort study in rural Japan. Clin Infect Dis 2003;37:1067–1072. 62.Klein PD, Graham DY, Gaillour A, Opekun AR, Smith EO. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet 1991;337:1503-1506. 63.Hopkins RJ, Vial PA, Ferreccio C, Ovalle J, Prado P, Sotomayor V, Russell RG, Wasserman SS, Morris JG Jr. Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission. J Infect Dis 1993;168:222-226. 64.Fujimura S, Kato S, Kawamura T. Helicobacter pylori in Japanese river water and its prevalence in Japanese children. Lett Appl Microbiol 2004;38:517–521. 65.Hulten K, Han SW, Enroth H, Klein PD, Opekun AR, Gilman RH, Evans DG, Engstrand L, Graham DY, El-Zaatari FA. Helicobacter pylori in the drinking water in Peru. Gastroenterology 1996;110:1031-1035. 66.McKeown I, Orr P, Macdonald S, Kabani A, Brown R, Coghlan G, Dawood M, Embil J, Sargent M, Smart G, Bernstein CN. Helicobacter pylori in the Canadian arctic: seroprevalence and detection in community water samples. Am J Gastroenterol 1999;94:1823-1829. 67.Hultén K, Enroth H, Nyström T, Engstrand L. Presence of Helicobacter species DNA in Swedish water. J Appl Microbiol 1998;85:282-286. 68.Sung JJY. Factors associated with disappearance of Helicobacter pylori in the Far East. Helicobacter pylori: Basic Mechanisms to Clinical Cure 2000;53–56. 69.Zaterka S, Eisig JN, Chinzon D, Rothstein W. Factors related to Helicobacter pylori prevalence in an adult population in Brazil. Helicobacter 2007;12:82-88. 70.Malaty HM, Kim JG, Kim SD, Graham DY. Prevalence of Helicobacter pylori infection in Korean children: inverse relation to socioeconomic status despite a uniformly high prevalence in adults. Am J Epidemiol 1996;143:257-262. 71.Naja F, Kreiger N, Sullivan T. Helicobacter pylori infection in Ontario: prevalence and risk factors. Can J Gastroenterol 2007;21:501-506. 72.Taiwan Department of Health Executive Yuan http://www.doh.gov.tw/EN2006/index_EN.aspx 73.Gold BD, Khanna B, Huang LM, Lee CY, Banatvala N. Helicobacter pylori acquisition in infancy after decline of maternal passive immunity. Pediatr Res 1997;41:641-646. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37264 | - |
dc.description.abstract | 幽門螺旋桿菌 (Helicobacter pylori) 感染是常見的感染,在開發中和已開發國家,成人幽門螺旋桿菌的流行率分別是80-90%和50%左右。幽門螺旋桿菌是消化性潰瘍疾病、慢性胃炎、胃癌等的主要致病原之一。由於廣泛的流行和臨床上的重要性,幽門螺旋桿菌感染是公共衛生的重要課題,而流行病學研究將提供資訊並應用於上消化道疾病,如消化性潰瘍的預防及處理,和高危險癌症族群如胃癌的篩檢調查及未來預防幽門螺旋桿菌之對策制定:例如何時接受疫苗或何時是幽門螺旋桿菌高初感染年紀,何時應積極治療幽門螺旋桿菌感染等 ; 因此,幽門螺旋桿菌感染流行病學研究及相關危險因子的分析是急迫必須的。台灣目前並無一個完整概括全台灣之有關幽門螺旋桿菌之流行病學調查,為了更完整瞭解全台灣幽門螺旋桿菌流行情況、幽門螺旋桿菌感染的危險因子、母親與嬰兒幽門螺旋桿菌抗體的相關性,並且藉由與1989年所作台灣血清幽門螺旋桿菌陽性率,來比較幽門螺旋桿菌這10年來在各年齡層感染幅度的變化及是否有period effect的存在,我們從1999年1月到1999年7月在台灣的5 個地區,透過系統取樣的方法收集了3644 人的血清及120對母親與嬰兒之血清樣本;並採用enzyme-linked immunosorbent assay(EIA)的方法偵測幽門螺旋桿菌抗體。每個個案需完成一關於基本資料、居住地區、家中小孩和大人人數、飲用水來源、有無上托兒所或給褓母帶、和小孩的主要照顧者等的問卷。在這項研究中,年齡調整後的幽門螺旋桿菌之全台灣血清盛行率是43.9%。幽門螺旋桿菌之血清盛行率在北台灣(台北)、東部(宜蘭)、西北部(桃園)呈現年齡特定的逐步上升,但是,在西部(台中)、南部(高雄)則呈現雙峰曲線的變化。在年齡不到二十歲的族群中,血清盛行率為20%,並有特定地區變異(p<0.001),在西部(台中 37.3%)、南部(高雄34.0%)有較高的陽性率,在北台灣(台北5.0%)、西北部(桃園11.5%)、東部(宜蘭10.1%)的陽性率較低 ; 相較於2186位未被感染的族群,561位感染幽門螺旋桿菌的個案中,男性比率較高(55.7% vs 50.8%,p<0.05),使用地下水/井水/河水為飲用水的較多(30.8% vs 22.7%,p<0.001),居住在西部及南部的較多(73.4% vs 34.5%,p<0.001),家中孩童數較少(2.34 vs 2.49,p=0.001)。小於20歲的個案中,在東北部、西部、南部,有較高比率的人使用地下水/井水/河水為飲用水,尤其是南台灣高達52.4%,且飲用地下水/井水/河水的比率與幽門螺旋桿菌血清陽性率有顯著相關(r=0.32 and p= 0.037)。年齡大於二十歲的血清盛行率為55%,不因不同地區而不同。與林肇堂教授在西元1989年於台灣四大區域幽門螺旋桿菌血清流行病學報告比較,每一年齡層的盛行率,現今都較1989年的為低,從1989 到1999年幽門螺旋桿菌血清盛行率之下降應與社經地位和衛生保健情況之進步相關。此外,在母親抗體對嬰兒抗體的影響分析中,幽門螺旋桿菌血清陽性的媽媽經由胎盤傳給嬰兒的幽門螺旋桿菌血清抗體於嬰兒5個月大時消失。
鑑定幽門螺旋桿菌感染的來源和傳染途徑在預防幽門螺旋桿菌感染是很重要的;幽門螺旋桿菌的感染來源目前仍然不確定,有些流行病學證據顯示,水是一個可能的來源,本研究採用即時聚合酶連鎖反應(real-time polymerase chain reaction) 的方法來偵測環境中的水和飲用水中幽門螺旋桿菌Ure A gene之存在,本實驗水樣本離心抽取步驟及real-time PCR的 recovery efficiency 大約為 50% ,目前採集的水檢體real-time PCR結果是陰性的,雖然是陰性結果,但對偵測水中幽門螺旋桿菌之存在,建立了一個標準流程,以期往後能大範圍全面的篩檢偵測水中幽門螺旋桿菌之存在,尤其是飲用水,以期在預防幽門螺旋桿菌感染上能有所助益。 | zh_TW |
dc.description.abstract | Helicobacter pylori (H. pylori) infection is common throughout the world, and the prevalence of H. pylori varies between developing and developed countries, where prevalence among adults is typically around 80-90% and 50%, respectively. H. pylori infection is a major factor in the etiology of peptic ulcer disease、chronic gastritis、gastric cancer、gastric mucosa-associated lymphoid tissue lymphoma, and so on. Owing to the widespread prevalence and clinical significance, infection with H. pylori constitutes an issue of major public health importance and H. pylori seroepidemiology study would provide information in the management and prevention of upper digestive disease such as peptic ulcer and survey of high-risk cancer population. It is thus urgent to study seroprevelance of H. pylori in Taiwan and explore the factors associated with H. pylori infection. The previous H. pylori epidemiology reports in Taiwan had limited age range, small location distribution of Taiwan, or incomplete data on the seroepidemiology of H. pylori. In this study, we investigated the seroprevalence and the risk factors associated with H. pylori infection in five different areas covering the eastern, western, northwestern, western and southern Taiwan. Sera of 120 pairs of infants and their mothers, and 3644 people, were collected in Jan-July 1999 in five areas of Taiwan including Taoyuan, Ilan, Taichung, Taipei City and Kaohsiung City. The Helicobacter pylori antibody was detected with EIA (enzyme-linked immunosorbent assay) commercial kit (IBL: immuno-biological immunoassay). All the subjects completed a structured questionnaire regarding demographic data, residential area, numbers of children and adults in a family, travel history, sources of water supply, etc. Statistical analysis was performed using logistic regression and the chi-square test. The overall age-adjusted H. pylori seroprevalence in Taiwan was 43.9%. Age-specific stepwise increase of H. pylori seroprevalence was found in northern (Taipei), eastern (Ilan), and north-western (Taoyuan) Taiwan but a biphasic curve was found in western (Taichung) and southern (Kaohsiung) Taiwan. People younger than 20 years old had H. pylori seropositivity rate of 20.0% with significant geographic variation (p<0.001): higher positive rates in western (37.3%) and southern Taiwan (34.0%) than in northern (5.0%), north-western (11.5%) and eastern Taiwan (10.1%); river/underground/well water used as drinking water source, living in western and southern Taiwan, male gender and less children number in the family were factors associated with H. pylori infection. A significant correlation of H. pylori seropositivity and the rates of drinking river/underground/well water was found (r=0.32 and p=0.037). Higher percentage of people used well/underground/river water as drinking water source in northeastern, western, and southern Taiwan, esp southern Taiwan (52.4%). People aged older than 20 years had overall seroprevalence rate of 55% without geographic difference. Our current study shows that the age-specific seroprevalence of H. pylori in 1999 declined one decade later in comparison with the age-specific seroprevelance in 1989. Socioeconomic status and hygiene condition improvement are assumed to be responsible for the declined H. pylori prevalence. Transplacentally transferred maternal anti-H. pylori IgG disappeared in all the infants by 5 months of age.
While the sources of H. pylori infection remain uncertain, epidemiological evidence suggests that water is one potential source. In our study, we thus tried to detect H pylori in water by real-time polymerase chain reaction (real-time PCR). A total of 44 water samples were collected from river/lake/spring/tap/underground water in different areas in Taiwan. H. pylori Ure A gene was examined using real-time PCR after centrifugation and DNA extraction of water samples. The recovery efficiency of serial centrifugation、DNA extraction、and real-time PCR was around 50%. H. pylori was not detected in current water samples. Although negative results, we constructed a standard protocol to detect H. pylori in water and hoped the method be applied in detecting H. pylori in water on large scale, esp the drinking water. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T15:22:51Z (GMT). No. of bitstreams: 1 ntu-97-P95421021-1.pdf: 783609 bytes, checksum: e610adda3a7573eb3c9043365e958d4d (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 口試委員會審定書------------------------------------ I
誌謝------------------------------------------------II 中文摘要-------------------------------------------III 英文摘要---------------------------------------------V 一、緒論 --------------------------------------------1 1.1 幽門螺旋桿菌之流行病學調查----------------------1 1.2 偵測水中幽門螺旋桿菌之存在-----------------------3 二、研究方法與材料 ----------------------------------3 2.1幽門螺旋桿菌之流行病學調查------------------------3 2.2偵測水中幽門螺旋桿菌之存在------------------------4 2.3 統計分析-----------------------------------------8 三、結果---------------------------------------------8 3.1幽門螺旋桿菌之流行病學調查 <一>特定年齡層及特定地區的幽門螺旋桿菌之血清盛行率---8 <二>小於20歲感染幽門螺旋桿菌的危險因子---------------9 <三>大於20歲感染幽門螺旋桿菌的危險因子--------------10 <四>在五地區水源與幽門螺旋桿菌血清盛行率的相關性----10 <五>母親幽門螺旋桿菌血清抗體對嬰兒抗體的影響--------10 3.2水中幽門螺旋桿菌之偵測結果-----------------------10 四、討論 -------------------------------------------11 五、結論展望----------------------------------------15 六、英文論述 ---------------------------------------16 七、參考文獻 ---------------------------------------28 八、圖表 -------------------------------------------39 表目錄 表一、台灣北中南地區腸病毒血清流行病學探究問卷------------39 表二、台灣各區域、各種水源水樣本採集個數------------------40 表三、Internal Control,recovery efficiency--------------40 表四、不同年齡層個案分布----------------------------------41 表五、小於20歲感染幽門螺旋桿菌的危險因子-單變項分析------41 表六、小於20歲感染幽門螺旋桿菌的危險因子-多變項分析------42 表七、大於20歲感染幽門螺旋桿菌的危險因子-單變項分析------42 表八、大於20歲感染幽門螺旋桿菌的危險因子—多變項分析-----43 表九、在五地區水源與幽門螺旋桿菌血清盛行率的相關性--------43 圖目錄 圖一、幽門螺旋桿菌ATCC43504 strain 電泳圖-----------------44 圖二、幽門螺旋桿菌TA clone plasmid定序sequence------------44 圖三、以real-time PCR Standard curve and negative control-44 圖四、全台灣各年齡層幽門螺旋桿菌血清盛行------------------45 圖五、宜蘭縣市各年齡層幽門螺旋桿菌血清盛行----------------45 圖六、桃園縣市各年齡層幽門螺旋桿菌血清盛行率--------------45 圖七、台北市各年齡層幽門螺旋桿菌血清盛行率----------------46 圖八、台中縣市各年齡層幽門螺旋桿菌血清盛行率--------------46 圖九、高雄縣市各年齡層幽門螺旋桿菌血清盛行率--------------46 圖十、綜合台灣五區域各年齡層幽門螺旋桿菌血清盛行率--------47 圖十一、母親抗體對嬰兒抗體的影響--------------------------47 圖十二、水中幽門螺旋桿菌之偵測結果 -----------------------48 圖十三、比較1989年及1999年的研究-------------------------48 | |
dc.language.iso | zh-TW | |
dc.title | 臺灣五區域幽門螺旋桿菌血清流行病學研究及水中幽門螺旋桿菌之偵測 | zh_TW |
dc.title | Helicobacter pylori seroepidemiology in five areas of Taiwan and real-time PCR assay for detection of Helicobacter pylori in water | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 黃立民(Li-Min Huan) | |
dc.contributor.oralexamcommittee | 吳明賢,劉俊人 | |
dc.subject.keyword | 幽門螺旋桿菌,血清流行病學,危險因子,台灣,水,即時聚合酶,連鎖反應, | zh_TW |
dc.subject.keyword | Helicobacter pylori,seroprevalence,risk factors,Taiwan,real-time PCR,water, | en |
dc.relation.page | 48 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-07-23 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
顯示於系所單位: | 臨床醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 765.24 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。